Go, Epifania C.
HRN: 00-02-45 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/03/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
11/03/2025
11/10/2025
IV
600mg
Q8hrs
Cellulitis
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes